Sift Biosciences
Recent Finacing
Pre-Seed
Recent Raise
$3.7M
Sift Biosciences is a UC Berkeley spin-out developing AI-enabled peptide therapeutics that harness pre-existing memory T cells to treat immunologically “cold” cancers and other immune disorders.
Highlights
Focus Areas
Biopharma
Biotechnology
Life Science
Recent Investors
Financials
$3.7M
Total Raised
1
Funding round